000 01573 a2200433 4500
005 20250518065851.0
264 0 _c20200403
008 202004s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-019-6300-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNiveditha, Divya
245 0 0 _aTranscriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday.
_h[electronic resource]
260 _bBMC cancer
_cNov 2019
300 _a1045 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCell Line, Tumor
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aCytokine Receptor gp130
_xgenetics
650 0 4 _aDown-Regulation
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Ontology
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aInterleukin-1 Receptor-Associated Kinases
_xgenetics
650 0 4 _aOsteosarcoma
_xdrug therapy
650 0 4 _aSequence Analysis, RNA
650 0 4 _aTranscription Factor RelA
_xgenetics
650 0 4 _aWithholding Treatment
700 1 _aSharma, Harshita
700 1 _aMajumder, Syamantak
700 1 _aMukherjee, Sudeshna
700 1 _aChowdhury, Rajdeep
700 1 _aChowdhury, Shibasish
773 0 _tBMC cancer
_gvol. 19
_gno. 1
_gp. 1045
856 4 0 _uhttps://doi.org/10.1186/s12885-019-6300-2
_zAvailable from publisher's website
999 _c30276850
_d30276850